AMETEK, Inc.AME
NYSE•Industrials•Specialty Industrial Machinery
AMETEK, Inc. manufactures and sells electronic instruments (EIG) and electromechanical (EMG) devices in the United States and internationally. It operates through EIG and EMG segments. The company offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and metering devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and gas turbines sensors; dashboard instruments for heavy trucks and other vehicles; instrumentation and controls for food and beverage industries; and aircraft and engine sensors, embedded computing, monitoring, power supplies, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry. It also provides engineered medical components and devices, automation solutions, thermal management systems, specialty metals, and electrical interconnects; single-use and consumable surgical instruments, implantable components, and drug delivery systems; engineered electrical connectors and electronics packaging; precision motion control products for data storage, medical devices, business equipment, automation, and other application; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for thermal management, military and commercial aircraft, and military ground vehicles; and motors used in commercial appliances, food and beverage machines, hydraulic pumps, and industrial blowers, as well as operates a network of aviation maintenance, repair, and overhaul facilities. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.
AMETEK, Inc. (AME) reported trailing twelve months revenue of $7.60B as of March 2026, a 9.5% increase year-over-year. Quarterly revenue reached $1.93B, reflecting continued top-line momentum.
AMETEK, Inc. generated $1.53B in TTM net income, with quarterly EBITDA of $620.43M. The operating margin expanded from 26.3% to 26.7%, suggesting improving cost efficiency and pricing discipline.
The spread between operating margin (26.7%) and net margin (20.7%) indicates moderate non-operating costs. Net margin has improved from 20.3% a year ago, signaling stronger bottom-line efficiency.
AME trades at a P/E of 31.2x (a premium multiple) and a P/S of 6.3x. The price-to-book ratio of 4.4x reflects a moderate premium to book value.
The company generated $426.05M in free cash flow over the trailing twelve months, a 8.0% increase year-over-year, indicating cash generation ability. The balance sheet shows $16.31B in total assets with $1.06B in long-term debt against $10.92B in stockholders equity for a debt-to-equity ratio of 0.1, a conservative capital structure. Data based on the most recent quarterly reports.
Competitive analysis based on 21 quarters of fundamental data
Operating margins are stable at ~26.1%, suggesting durable pricing power and cost discipline.
ROE is positive at ~14.1% on average, adequate but below the threshold typically associated with wide moats.
8 of the last 8 quarters generated positive FCF. The company generally funds itself but has occasional cash consumption quarters.
TTM revenue has grown consistently (6 of 7 quarters up), with ~49.2% growth over the period. Strong demand durability.
Data-driven red flags and warnings across 21 quarters
Margins are stable or improving at ~25.9% — no sign of cost or pricing stress.
FCF covers net income by 1.2x on average — earnings are well-supported by cash generation.
D/E ratio is 0.1 — conservative capital structure with low financial risk.
Revenue is stable or growing over recent quarters — demand appears durable.
Free cash flow is consistently positive — the business self-funds without external capital reliance.
Share count is stable — no significant dilution or buyback activity.
Quarterly standardized metrics.
Stock price and market valuation
Revenue and earnings growth across quarters
Assets, cash, debt, and leverage
Price multiples and return ratios
Operating efficiency and return metrics
Free cash flow, earnings quality, and capital allocation